After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

At MD&M West, PIA will give attendees live demonstrations of its assembly technology, including V-RAC. In Booth 5328 in the ...

Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market- Targeting Q1 2026 for expected clearance of the MODD1 in th ...

When conducting a clinical investigation, meeting regulatory requirements is predicated on factors such as the quality of ...

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

In digital healthcare, AI drives innovations and improves patient outcomes by making processes more efficient.

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags. Read more on NRXS stock here.

forward-integrated approach to medical device development. For more information about Cortland Biomedical and its expanded capabilities as an FDA-registered contract manufacturer, visit ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...

Wilson Zhang MD MSc, CEO of IntelliGenome. The FDA Breakthrough Devices Program aims to expedite the development, evaluation, and approval of innovative technologies designed to address irreversibly ...